Belimumab in Patients with Chronic Lymphocytic Leukemia

Clinical trial NCT05069051 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05069051
Sponsor: University Hospital Tuebingen
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Lymphoid Leukemia in Relapse

Start date: 2022-01-19
Primary completion: 2026-07-15
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.